The pharmaceutical industry faces significant challenges in its mission to provide safe, effective, and affordable products. Noam Nahari, VP marketing & business development at LOG Pharma Primary Packaging discusses.
Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), has announced an international collaboration with Thermo Fisher Scientific.
Aragen, a contract research, development and manufacturing organisation (CRDMO), announced that it will commence GMP manufacturing at its biologics manufacturing facility in Bangalore, India from July 2025.
Shilpa Biocare, a fully-owned subsidiary of Shilpa Medicare, announces ahead of BIO Boston that it has secured a Europe-wide commercial supply agreement with Orion Corporation for Recombinant Human Albumin.
TekniPlex Healthcare, which utilises advanced materials science expertise to help deliver better patient outcomes, has commenced production activities at its new 200,000-square-foot facility in Madison, Wisconsin.
Sumeet Dalvi from Emerson explains how software platforms that manage product and manufacturing specifications enable seamless and rapid technology transfers.
Dr. Werner Engelbrecht, senior director strategy, Veeva Systems explores how this year could see clinical trial innovation surge as EU regulation evolves.
Oxford-based SynaptixBio, which is developing a therapy for a rare, deadly, and currently incurable rare disease (H-ABC), says it has identified the drug it will take forward into clinical trials.
Schneider Electric, a company in the digital transformation of energy management and automation, has announced new data centre solutions specifically engineered to meet the intensive demands of next-generation AI cluster architectures.
